Skip to Content
Merck
CN

436097

4-Fluoro-2-(trifluoromethyl)benzaldehyde

98%

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
FC6H3(CF3)CHO
CAS Number:
Molecular Weight:
192.11
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

4-Fluoro-2-(trifluoromethyl)benzaldehyde, 98%

InChI

1S/C8H4F4O/c9-6-2-1-5(4-13)7(3-6)8(10,11)12/h1-4H

SMILES string

Fc1ccc(C=O)c(c1)C(F)(F)F

InChI key

NONOHEMDNFTKCZ-UHFFFAOYSA-N

assay

98%

form

liquid

refractive index

n20/D 1.452 (lit.)

bp

114 °C (lit.)

density

1.408 g/mL at 25 °C (lit.)

General description

4-Fluoro-2-(trifluoromethyl)benzaldehyde is an organic fluorinated building block. It participates in the synthesis of diphenylthioethers. It also participates in the preparation of 1-cyano derivative of nilutamide.

pictograms

FlameExclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 3 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

3 - Flammable liquids

wgk

WGK 3

flash_point_f

134.6 °F - closed cup

flash_point_c

57 °C - closed cup

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Peter S Cogan et al.
Journal of medicinal chemistry, 46(24), 5258-5270 (2003-11-14)
The synthesis and preliminary evaluation of a doxorubicin-formaldehyde conjugate tethered to the nonsteroidal antiandrogen, cyanonilutamide (RU 56279), for the treatment of prostate cancer are reported. The relative ability of the targeting group to bind to the human androgen receptor was
Lorna Mitchell et al.
Bioorganic & medicinal chemistry letters, 19(5), 1310-1313 (2009-02-10)
The first examples of thioether-substituted benzonitriles as potential soft-drug androgen receptor antagonists are reported. A number of 4-(alkylthio)- and of 4-(arylthio)-benzonitrile analogs were evaluated in human androgen receptor binding and cellular functional assays. Analogs with potent in vitro binding and

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service